Caldwell Sutter Capital’s Procept Biorobotics PRCT Stock Holding History

Caldwell Sutter Capital’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.3K	Buy	+1,385	New	+$34.7K	0.01%	471

Other funds holding PRCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Caldwell Sutter Capital's PRCT Position: Q2 2026 in Review

Caldwell Sutter Capital opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 1,385 shares worth $31.3K. The stake represents 0.01% of the portfolio and ranks #471 among its holdings.

254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

Caldwell Sutter Capital held 1,385 shares of Procept Biorobotics worth $31.3K as of Q2 2026.
Procept Biorobotics was a new Caldwell Sutter Capital position in Q2 2026.
Procept Biorobotics made up 0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #471 holding.
254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.